NEW YORK, Feb. 1 /PRNewswire/ -- QED International Associates, Inc, administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded Funds, today announced that effective at the opening of trading on Thursday February 7, 2008, Analogic Corporation (Nasdaq: ALOG) will replace Ventana Medical Systems, Inc. (Nasdaq: VMSI) in the HealthShares(TM) Diagnostics Index. Ventana's is being acquired by Roche group based in Switzerland.
Companies that are included in The HealthShares(TM) Diagnostics Index are engaged in the identification of the existence and extent of a disease, the visual localization of a disease by way of imaging, the selection of therapeutic agents appropriate for the disease wherever possible and the monitoring of disease progression/therapeutic efficacy.
About QED International Associates
QED International, based in New York, is a leading financial industry consulting firm specializing in quantitative modeling and the design, development and maintenance of indexes and Exchange Traded Funds. For more information, visit the company's website at http://www.qedinternational.com
|SOURCE QED International|
Copyright©2008 PR Newswire.
All rights reserved